Furthermore, this data drives clinical research into why certain populations develop ER+ tumors and how to optimize treatments to overcome potential resistance to hormonal therapies over time. The determination of receptor status is typically performed through immunohistochemistry (IHC) on a biopsy sample, providing a definitive classification that guides the entire therapeutic strategy.
Optimizing Care with ICD-10 Code Specificity for Estrogen Receptor Positive Breast Cancer
Data, Research, and Public Health On a population level, the specificity of the ICD-10 coding for estrogen receptor status provides invaluable data for public health officials and researchers. Laterality Extension: Characters 4 and 5 specify the side (1=right, 2=left, 3=bilateral, 4=unspecified).
These medications work by blocking the body's ability to produce estrogen or by preventing estrogen from attaching to the cancer cells, thereby slowing or stopping the progression of the disease. 9 cases allows for the analysis of trends, the evaluation of screening programs, and the allocation of resources for support services.
Optimizing Care with ICD-10 Code Specificity for Estrogen Receptor Positive Breast Cancer
Anatomic Site: Characters 6 and 7 specify the quadrant (e. Understanding Estrogen Receptor Status The designation "estrogen receptor positive" refers to the presence of a high density of estrogen receptors on the surface of cancer cells.
More About Estrogen receptor positive breast cancer icd 10
Looking at Estrogen receptor positive breast cancer icd 10 from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Estrogen receptor positive breast cancer icd 10 can make the topic easier to follow by connecting earlier points with a few simple takeaways.
